Introduction
Directly-linked 2,4-azoles are found in natural products that have interesting biological activities and fascinating structures. Numerous bis-and tris-oxazoles, as well as a few oxazole-thiazoles, have been isolated from marine organisms, whereas linked thiazole-containing natural products have generally been obtained from microorganisms. 1 Marine organism secondary metabolites such as ulapualides, 2 halichondramides, 3 kabiramides, 3 mycalolides, 4 halishigamides, 5 and jaspisamides, 6 all contain a trisoxazole fragment. These compounds show a broad range of unusual biological activities. 7 Telomestatin, a potent telomerase inhibitor isolated from Streptomyces anulatus 3533-SV4 8 that interacts specifically with the human telomeric intramolecular Gquadruplex without affecting DNA polymerases or reverse transcriptases, contains a novel macrocyclic structure comprised of seven linked oxazoles and one thiazoline unit. A related cyclopeptides, YM-216391, containing only four oxazoles and one thiazole, has been isolated from Streptomyces nobilis. Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com)
Scheme 1. Macrocyclization in the syntheses of YM-216391, tetomestatin, and IB-01112
A more recently discovered macrocyclic peptide, IB-01211 ( Figure 1 ), has been isolated from the marinederived microorganism strain ES7-008, which is phylogenetically close to Thermoactinomyces genus. 10, 11 It is strongly cytotoxic against several tumor cell lines, 12 and contains four oxazoles and one thiazole.
Concatenated azoles have been prepared following several strategies, 1c including cyclodehydration of peptides containing serine, threonine or cysteine followed by oxidation of the azoline to azole; the classical Hantzsch synthesis allowing a one-pot synthesis of the azole-ring; Pd(0) catalyzed cross-coupling reaction-despite difficulties in the preparation of several precursors; sequential [3 + 2] cycloaddition of an appropriate rhodium carbene with nitriles, a new route to polyoxazoles from an ulapualide fragment; sequential Chan-type rearrangements of tertiary amides for the preparation of trisoxazoles; and finally, iterative oxazole assembly via base-promoted cyclization of alkynyl glycine derivatives prepared from the corresponding -chloroglycinates by reaction with alkynyl dimethylaluminum reagents. The total syntheses of YM-216391, 13 telomestatin, 14 and IB-01211 15 have recently been described. The three procedures possess a common feature, a macrocyclization of flexible precursors (Scheme 1).
The key step in the aforementioned synthesis of IB-01211 is macrocyclization by Hantzsch formation of the thiazole ring. Alternatively, the macrocyclization could be envisaged through formation of an amide bond between penta-azole peptides 1 and 2 as the last synthetic step (see Figure 2 ). Thus, with the aim of synthesizing IB-01211 and related derivatives, we studied the macrocyclization of penta-azole containing peptides. We describe here the preparation of several open chain IB-01211 derivatives, including subsequent macrocyclization studies and antitumor activity screening.
Results and Discussion

Figure 2 Retrosynthetic analysis of IB-01211
The retro-synthetic strategy used for this work is shown in Figure 2 . Disconnection of the amide bonds between the D-Val and the aminoethylidene (disconnection a), or between the D-Allo-Ile and the phenyloxazolcarbonyl (disconnection b), affords the penta-azolepeptides 1 or 2, respectively. Both peptides possess a tert-butyl protected alcohol, which can be readily transformed into the exocyclic methylidene present in the natural compound. The strategy involving intermediate 1 was thought to be more favorable than that with 2, which involves a coupling reaction of a hindered -amine and a poorly reactive carboxylic group. A less convergent strategy through amide bond formation between the hindered Ile and Val residues was rejected. The common precursors 
Synthesis of penta-azole 3
Preparation of 3 was attempted by transformation of peptide 7a into thioamide 7b, followed by cyclization and oxidation (Scheme 2A). 16 Reaction of the acid 5a and the amine 6a using the general procedure described in the experimental section for peptide bond formation afforded 7a in good yield. 17 The bis-oxazole derivative 5a was obtained by cyclization of the proper Ser peptide followed by oxidation of the resulting oxazolines, as previously described by our group. 15 However, reaction of 7a with the Lawesson reagent to produce the thioamide 7b gave a complex mixture from which no product could be isolated.
After exploring a broad range of reagents and conditions to afford the thiazole moiety, including the use of a cysteine-containing building block, 18 we took a major shift in strategy: a classical Hantzsch synthesis using a thioamide and an -bromoketone (Scheme 2B).
Bisoxazole 10, containing the protected -bromoketone residue for the Hantzsch synthesis, was obtained by two sequential oxazole-ring formations in order to minimize the amount of byproduct resulting from water elimination, and also because formation of a conjugated carbon-carbon double bond is favored by the presence of the phenyl ring. Cyclization and oxidation of dipeptide 8 19 afforded an oxazole with a protected amino ethanol-substituent at position 2 of the ring, which was then deprotected with 95% trifluoroacetic acid (TFA) to give the amino alcohol 9. Compound 9 was used in the following amide bond formation by reaction with bromopyruvic acid dimethyl acetal. Subsequent ring closure and oxidation then provided 10. Elimination of the acetal protecting group of 10 by treatment with formic acid at reflux gave the bromoketone 6b in quantitative yield. Penta-azole 3 was obtained in a 62% yield by Hantzsch thiazole synthesis using the bis-oxazolethioamide 5b and the bis-oxazolyl -bromomethyl ketone 6b. It was characterized by 1 H-NMR, whereby the four singlets in the aromatic region, and the five aromatic protons, were taken as representative signals. by methyl ester hydrolysis, respectively. With pentaazole 3 and epimeric peptides 4 and 4a in hand, we considered two options for macrocyclization, both of which implied preparation of peptides 1 and 2 (Scheme 3). The macrocyclization studies were performed with 4a, as it is the cheaper of the two peptides.
Macrocyclization reaction
Compound 1a was prepared in good yield by methyl ester hydrolysis of 3 with LiOH, followed by condensation with N-deprotected-4a using EDC·HCl and HOBt as activating agents, and N,N-diisopropylethylamine (DIEA). In parallel, 2a was also obtained with good yields, by Nand O-deprotection of 3 with 95% TFA, followed by condensation with the acid obtained in the saponification of 4a, as described above. 
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Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com) pentafluorophenyl ester, N-deprotection 20 and, finally, macrocyclization by treatment with DIEA in a highly diluted THF solution gave the cyclic peptide 12a (Scheme 3).
The exocyclic methylidene of 12b was prepared by Odeprotection and dehydration of 12a using mesyl chloride as activating agent and N,N,N-triethylamine (TEA) in THF. It was characterized by 1 H-NMR, whereby the two methylidene singlets at 6.06 and 6.70 ppm, and the four singlets of the azole rings (7.96, 8.20, 8.27 , and 8.30 ppm), were taken as representative signals. 21 As the yield of this macrocyclization was poor (less than 10%), we decided to test cyclization using a copper salt template.
The peptide-heterocycle 1 (R 1 = Me, R 2 = Boc) was obtained by condensation of the free carboxylic acid of 3 with the free amine of 4, using the same reaction conditions described above for 1a. Similar conditions were also used for the methyl ester hydrolysis of 1, conversion of the resulting acid into the pentafluorophenyl ester followed by selective Ndeprotection. Macrocyclization was then attempted using DIEA and CuSO 4 in a highly dilute THF solution. Unfortunately, no trace of the cyclized product was found, and only the pentafluorophenyl ester 13 of the open chain peptide-heterocycle was obtained.
Biological activity
The cytotoxicity of the concatenated azoles was evaluated against a panel of three human tumor cell lines: A-549 lung carcinoma NSCL, HT-29 colon carcinoma, and MDA-MB-231 breast adenocarcinoma. A conventional colorimetric assay was run to estimate GI 50 values (i.e. the drug concentration at which 50% of cell growth is inhibited after 72 hours of continuous exposure to the test molecule), in which IB-01211 was for comparison.
The results obtained are shown in Table 1 . A decrease of activity of compounds 3, 1, and 13 in relation with IB-01211 has been observed. Penta-azole 3 possess activity at micromolar (M) concentration in the three cell lines, whereas 1 possess the same activity only in A-549 and 13 is inactive. The natural compound, IB-01211, shows activity in the three lines at nanomolar concentration. None of the peptides with D-Ile, 2a, 12a, and 12b, has notable activity. These results demonstrate the importance of the configuration of the stereocenter to the activity of these compounds. 
Conclusions
Herein we have reported preparation of the functionalized polyazoles 6a, 6b, 7a, the penta-azole 3, and the peptideheterocycles 1, 1a, 2a, 12a, 12b, and 13. Attempts at macrocyclization using the amino acids from the deprotection of 1 and 2 only led to a small amount of cyclized product, underscoring the need to change the synthetic strategy. Likewise, macrocyclization of N-and C-deprotected 1 using a copper chelating group also failed. While 1 and 2 possess an almost planar polyheterocyclic system of penta-azoles that separate the reactive groups the shown precursor of IB-01211 posses bigger conformational freedom which made the macrocyclization easier.
The open chain polyazoles with the same stereocenter configuration as the natural product inhibit growth of human carcinoma cells (GI 50 ) at micromolar concentrations, whereas the epi-analogs obtained with DIle are inactive.
Experimental section
General. Hydrolysis of methyl esters 2M LiOH (9 mmol) was added to a solution of methyl ester (3 mmol) in THF-H 2 OMeOH (50:6:0.2, 14 mL), and the reaction mixture was stirred at room temperature for 1 h. The pH of was brought to 3 by addition of 1M HCl, and then the solution was extracted with EtOAc. The organic layer was dried over MgSO 4 and concentrated to afford the acid as a white solid.
Deprotection with TFA
Method A.
Elimination of N-Boc and O-tert-Bu protecting groups. 95% TFA (5 mL) was added to a solution of the di-protected (N-Boc and O-tert-Bu) compound (2.38 mmol), and the solution was stirred at room temperature for 5 h. The TFA was then removed ---under reduced pressure, and the crude material was used for subsequent chemistry without further purification.
Method B. Selective elimination of N-Boc protecting group.
A solution of N-Boc protected compound (27 mol) in TFA-CH 2 Cl 2 (1 mL, 3:7) was stirred at room temperature for 1 h. The TFA and the solvent were removed, and the crude material was used for subsequent chemistry without further purification.
Peptide 1 (R 1 = Me, R 2 = Boc). Coupling of the free carboxylic acid of 3 to the free amine of 4 using the general procedure for peptide formation provided 1 (70%) as a white solid, m. p. (MeCN) 186-188 
Methyl 2'-{2-[2'-(2-tert-butoxy-1-tert-butoxycarbonylaminoethyl)-[2, 4']bis-oxazol-4-yl]thiazol-4-yl}-5-phenyl[2,4']bis-oxazolyl-4-carboxylate (3)
Bromoketone 6b (64 mg, 0.16 mmol) was added to a suspension of 5b (45 mg, 0.11 mmol) and NaHCO 3 (29 mg, 0.35 mmol) in THF (2 mL). The mixture was stirred for 8 h at room temperature, at which point it was filtered over alumina and washed with CH 2 Cl 2 -MeOH (4:1). The organic layer was concentrated to give a crude material which was dissolved in dry THF (2 mL) and cooled to -10 ºC. Lutidine (0.10 mL, 0.87 mmol) and TFAA (46 L, 0.33 mmol) were then added to the solution, and the reaction mixture was stirred at room temperature overnight. Concentration in vacuo gave a brown residue, which was purified by silica gel chromatography. Elution with CH 2 Cl 2 /EtOAc (9:1) gave 3 (47.8 mg, 62%) as a white solid, m. p. (MeCN) 
Methyl 2'-(2-tert-butoxy-1-tert-butoxycarbonylaminoethyl)-5-phenyl[2, 4']bis-oxazolyl-4-carboxylate (6)
The free amine of 9 was coupled with Boc-L-Ser(tBu)-OH following the general procedure for peptide formation. Cyclization using DAST/K 2 CO 3 and oxidation with DBU-CCl 4 in Pyr and ACN as solvents gave a crude which was purified by column chromatography on silica gel. Elution with hexane/ EtOAc (3:1) gave 6 (50%) as a solid, m. p. (MeCN) Create PDF files without this message by purchasing novaPDF printer (http://www.novapdf.com) washed with 5% aqueous NaHCO 3 and aqueous NH 4 Cl. The organic solution was dried and concentrated, and the residue was diluted with TFA-CH 2 Cl 2 (6 mL and 14 mL). The solution was stirred for 1 h at room temperature, and then the TFA was removed, and the crude material was dissolved in THF (250 mL). DIEA (479 L, 2.82 mmol) was added, and the mixture was stirred for 96 h at room temperature. The solvents were removed, and the residue was then washed with MeOH. The residue obtained after removing the solvent was purified by preparative HPLC. A gradient of H 2 O (0.045% TFA) / MeCN (0.036% TFA) from 6:4 until 1:9 in 15 min gave a white solid (10 mg, 9%, rt = 7.47 min), m. p. (MeCN) Peptide 13 A solution of carboxylic acid (150 mg, 0.166 mmol) obtained from 1 in dry THF-DMF (10 mL and 2 mL) was cooled to 0 ºC. EDC·HCl (0.22 mg, 1.16 mmol), DIEA (0.19 ml, 1.16 mmol) and Pfp-OH (0.229 mg, 1.24 mmol) were then added, and the reaction mixture was stirred at room temperature for 20 h. The solvents were removed in vacuo, and the residue was diluted with CH 2 Cl 2 , and then washed with 5% aqueous NaHCO 3 and aqueous NH 4 Cl. The organic solution was dried and concentrated, and the residue was diluted in TFA-CH 2 Cl 2 (1 mL/3 mL). The solution was stirred for 1 h at room temperature, and then the TFA was removed. The crude material was dissolved in THF (300 mL). DIEA (0.28 ml, 1.66 mmol) and CuSO 4 (132 mg, 0.83 mmol) were added, and the mixture was stirred for 72 h at room temperature. The solvents were removed, and the crude was purified by silica gel chromatography (9:1 CH 2 Cl 2 -MeOH) to give 13
